DEUTSCHE BANK AG\ - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2023$28,098
+5.6%
1,7050.0%0.00%
Q4 2022$26,598
-14.2%
1,705
-27.7%
0.00%
Q3 2022$31,000
-6.1%
2,3590.0%0.00%
Q2 2022$33,000
-2.9%
2,3590.0%0.00%
Q1 2022$34,000
+6.2%
2,3590.0%0.00%
Q4 2021$32,000
-17.9%
2,3590.0%0.00%
Q3 2021$39,000
-2.5%
2,3590.0%0.00%
Q2 2021$40,000
-14.9%
2,359
-8.7%
0.00%
Q1 2021$47,000
-13.0%
2,585
-12.4%
0.00%
Q4 2020$54,000
-36.5%
2,951
-37.7%
0.00%
Q3 2020$85,000
+9.0%
4,740
+8.4%
0.00%
Q2 2020$78,000
-29.1%
4,374
-39.9%
0.00%
Q1 2020$110,000
-98.0%
7,279
-97.4%
0.00%
-100.0%
Q4 2019$5,476,000
+1075.1%
277,809
+919.4%
0.00%
Q3 2019$466,000
-57.6%
27,253
-56.2%
0.00%
-100.0%
Q2 2019$1,098,000
-77.7%
62,250
-74.3%
0.00%
-66.7%
Q1 2019$4,924,000241,9340.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders